Erase Imperfection MDA-A-128-05

Susonity
Phase
Product
INCI Name
Supplier
Volume
A

RonaCare® AP

BIS-ETHYLHEXYL HYDROXYDIMETHOXY BENZYLMALONATE

1

2.00

Xiameter® PMX-0345

CYCLOPENTASILOXANE, CYCLOHEXASILOXANE

2

5.00

Crodamol DA

DIISOPROPYL ADIPATE

3

7.00

Paraffin liquid

PARAFFINUM LIQUIDUM (MINERAL OIL)

1

2.00

B

Sepiplus 400

POLYSORBATE 20, POLYACRYLATE 13, POLYISOBUTENE

4

2.00

C

RonaCare® Salicylic Acid

Salicylic Acid

1

1.00

Timiron® Silk Green

CI 77891 (TITANIUM DIOXIDE), MICA, TIN OXIDE

1

3.00

RonaCare® Ectoin

ECTOIN

1

0.50

Glycerol 85%

GLYCERIN, AQUA (WATER)

1

3.00

Titriplex® III

DISODIUM EDTA

1

0.10

Preservatives

qs

Water, demineralized

ad 100

Preparation:

Dissolve ingredients of phase A until homogenus. Add B under stirring in the premixed phase C.Add A to B/C while stirring. Homogenize.Finally add phase D.

Notes:

Appearence: white gel with green shimmerpH (23°C): 3.5Viscosity: 20000 mPa.s (Brookfield RV II+, spindle C, 10rpm) at 23°CStability: 3 month at 40°C, FTC(-5°C to 40°C), 5°C, RT and 1 week at 50°C

(1) Merck KGaA, Darmstadt, Germany / EMD Chemicals (2) Dow Corning (3) Croda GmbH (4) Seppic GmbH (5) Schülke & Mayr GmbH

Disclaimer

While every effort has been made to reproduce these formulations correctly, the Publisher of this website cannot accept any liability for the information presented. All formulations are provided in good faith, but no warranty is given as to accuracy of information or results, or suitability for a particular use, nor is freedom from patent infringement to be inferred. Formulations are offered solely for consideration by the participating manufacturers. Continued use of this web site infers acceptance of this disclaimer.

Latest Issues

NYSCC Suppliers' Day 2026

Javits Center, New York
19 - 20 May

in-cosmetics Korea 2026

COEX, Seoul
1 - 3 July 2026